{"id":427215,"date":"2026-05-01T16:18:08","date_gmt":"2026-05-01T16:18:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/427215\/"},"modified":"2026-05-01T16:18:08","modified_gmt":"2026-05-01T16:18:08","slug":"melanoma-gut-microbiome-may-help-predict-recurrence-after-immunotherapy","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/427215\/","title":{"rendered":"Melanoma Gut Microbiome May Help Predict Recurrence After Immunotherapy"},"content":{"rendered":"<p>&#13;<\/p>\n<p>Gut bacterial markers may be able to predict recurrence in patients with high-risk melanoma receiving adjuvant immune checkpoint inhibition, according to study findings published in\u00a0<a href=\"https:\/\/www.cell.com\/cell\/abstract\/S0092-8674(26)00342-9\" rel=\"nofollow noopener\" target=\"_blank\">Cell<\/a>.\u00a0<\/p>\n<p>\u201cOur study identified for the first time gut bacterial types that can serve as markers of increased recurrence risk in these specific patients, which will help tailor treatment,\u201d said study senior author\u00a0Jiyoung Ahn, PhD, Professor in the\u00a0Department of Population Health\u00a0at NYU Grossman School of Medicine and Associate Director of Population Research at\u00a0Perlmutter Cancer Center.<\/p>\n<p>Study Methods\u00a0<\/p>\n<p>Researchers explored whether pretreatment gut microbiome features impact recurrence in patients with melanoma receiving immune checkpoint inhibition.\u00a0\u00a0<\/p>\n<p>\u201cPast studies have struggled because the gut bacteria that predict treatment success seemed to change from one region to another,\u201d said Dr. Ahn. \u201cOur study provides a new method that overcomes this barrier, showing that these markers are indeed generalizable if we account for the person\u2019s underlying microbiome.\u201d\u00a0<\/p>\n<p>The researchers analyzed stool samples from 674 patients who were enrolled in the phase III CheckMate 915 trial, which included patients with resected, high-risk, stage IIIB\u2013IV melanoma and investigated treatment with adjuvant nivolumab plus ipilimumab or nivolumab alone. They conducted region-specific and cross-region meta-analyses of gut microbiome composition.\u00a0<\/p>\n<p>Key Findings\u00a0<\/p>\n<p>Researchers found that pretreatment taxa, including\u00a0Eubacterium, Ruminococcus, Firmicutes, and\u00a0Clostridium,\u00a0were associated with melanoma recurrence.<\/p>\n<p>Prediction was strongest when the validation cohort showed profiles of gut microbiome similar to those in the discovery cohort, with areas under the curve for recurrence prediction ranging from 0.78 to 0.94 across regions in individuals with low Jensen-Shannon divergence figures (\u2264 0.11).<\/p>\n<p>The composition of the gut microbiome was mostly stable from pretreatment to posttreatment.\u00a0<\/p>\n<p>The study authors suggested that gut bacteria could serve as clinically actionable biomarkers to guide personalized therapy in patients with high-risk melanoma.\u00a0<\/p>\n<p>\u201cThis means that a single pretreatment microbiome test could provide a reliable forecast of a patient&#8217;s risk,\u201d said study author\u00a0Richard B. Hayes, DDS, PhD, MPH, Professor in the Department of Population Health, NYU Grossman School of Medicine. \u201cThe next step is to validate this matching approach in other cancers and to build the diverse databases needed to make this approach clinically feasible. In the future, we envision analyzing a patient\u2019s microbiome before treatment, comparing it to a global database, and providing a reliable prognosis that guides therapy from the start.\u201d\u00a0<\/p>\n<p>DISCLOSURES:\u00a0Funding for the study was provided by National Institutes of Health grants.\u00a0For full disclosures of the study authors, visit\u00a0<a href=\"https:\/\/www.cell.com\/cell\/abstract\/S0092-8674(26)00342-9\" rel=\"nofollow noopener\" target=\"_blank\">cell.com<\/a>.\u00a0<\/p>\n<p>&#13;<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; Gut bacterial markers may be able to predict recurrence in patients with high-risk melanoma receiving adjuvant immune&hellip;\n","protected":false},"author":2,"featured_media":427216,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[61,60,80],"class_list":["post-427215","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-ie","tag-ireland","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/427215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=427215"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/427215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/427216"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=427215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=427215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=427215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}